Comparison of HBsAg changes between HBeAg-negative patients who discontinued or maintained entecavir therapy.
Hepatol Int 2019;
14:317-325. [DOI:
10.1007/s12072-019-09991-y]
[Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Accepted: 09/27/2019] [Indexed: 12/19/2022]